Depression in perimenopause
You have never struggled with depression before. And yet here you are — feeling low, unmotivated, not quite yourself, in a way that doesn't lift. Or maybe you have a history of depression, and it's back in a way you didn't expect. Either way, if this started during perimenopause, there is a biological explanation — and it matters.
Here's what's actually happening
Depression during perimenopause is common in a way that most women are never warned about. Research shows that the risk of developing significant depressive symptoms is two to five times higher during perimenopause than before the transition — even in women who have never experienced depression before. Among women without any prior history, 10 to 30% develop clinically significant depressive symptoms during this window. For women who have had depression before, the rate is even higher.
The cause is not simply "low estrogen." That is a common misconception. What the research shows is that it's the instability of estrogen — the dramatic swings up and down that characterize perimenopause — that disrupts mood. In one study, 90% of perimenopausal women with depressive symptoms had fluctuating estradiol levels, and the more erratic the fluctuation, the worse the mood symptoms. Your brain has spent decades relying on relatively stable hormonal signals. When those signals become unpredictable, the systems that regulate mood, stress, and emotional resilience are all affected.
Progesterone plays its own role. As ovulation becomes irregular during perimenopause, progesterone levels drop — and low progesterone was independently associated with more severe depressive symptoms in the same research. The combination of unstable estrogen and declining progesterone creates real, measurable changes in the brain's mood-regulating chemistry. This is not emotional weakness. This is biology.
It is also worth knowing that some women are simply more sensitive to these hormonal fluctuations than others. There is no reliable way to predict who will be most affected. If you are, that sensitivity is real — and it is not a reflection of how you handle stress or difficulty.
In perimenopause vs. menopause
Mood symptoms tend to peak during perimenopause, when hormonal swings are at their most erratic. This is when the brain is most reactive. Women who spend longer in perimenopause tend to have a harder time with mood, because the period of instability lasts longer.
For most women, depressive symptoms improve after menopause, once hormone levels settle — even at lower levels — into a more stable state. A 2024 meta-analysis found that postmenopausal women did not show significantly increased depression risk compared to premenopausal women. The transition itself is the vulnerable window.
Hormone therapy has strong evidence for preventing depression during perimenopause, and it works differently than an antidepressant — it addresses the hormonal instability that is causing the problem rather than targeting symptoms directly. A landmark clinical trial found that transdermal estradiol combined with micronized progesterone cut the rate of clinically significant depressive symptoms nearly in half over 12 months compared to placebo. That benefit held even after accounting for any improvement in hot flashes, which means the mood benefit was direct and independent. The evidence is strongest when treatment begins in early perimenopause — this appears to be the critical window. A large real-world study of 920 women found that hormone therapy reduced depression scores by nearly 45% within about three and a half months.
The sources behind this page
- Badawy Y, Spector A, Li Z, Desai R. The risk of depression in the menopausal stages: a systematic review and meta-analysis. Journal of Affective Disorders. 2024.
- Brown L, Hunter MS, Chen R, et al. Promoting good mental health over the menopause transition. Lancet. 2024.
- Joffe H, de Wit A, Coborn J, et al. Impact of estradiol variability and progesterone on mood in perimenopausal women with depressive symptoms. The Journal of Clinical Endocrinology and Metabolism. 2020.
- Gordon JL, Sander B. The role of estradiol fluctuation in the pathophysiology of perimenopausal depression: a hypothesis paper. Psychoneuroendocrinology. 2021.
- Gordon JL, Rubinow DR, Eisenlohr-Moul TA, et al. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial. JAMA Psychiatry. 2018.
- Glynne S, Kamal A, McColl L, et al. Transdermal oestradiol and testosterone therapy for menopausal depression and mood symptoms: retrospective cohort study. The British Journal of Psychiatry. 2025.